| Ytd | -7.27% | |
| 1y | -4.48% |
| Open | 45.71 | Prev Close | 45.85 | Low | 45.27 | High | 45.80 | Mkt Cap | 14.02B |
| Vol | 1.25M | Avg Vol | 531.06K | EPS | 2.29 | P/E | 19.94 | Forward P/E | 17.65 |
| Beta | 0.42 | Short Ratio | 16.18 | Inst. Own | 57.06% | Dividend | 2.11 | Div Yield | 4.61 |
| Ex Div Date | 07-31 | Earning | 11-06 | 50-d Avg | 49.85 | 200-d Avg | 51.28 | 1yr Est | 53.00 |
EMA News
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Today Emera (TSX/NYSE: EMA) announced that it will release it
What happened Emera (NYSE: EMA), Canadian Utilities and ATCO agreed on Oct. 6, 2026, to combine in a
Emera and Canadian Utilities (TSX:CU) have agreed to merge, creating a Canadian utility and energy i
Emera and Canadian Utilities TSE: CU have agreed to combine in a predominantly all-share transaction
Emera TSE: EMA and Canadian Utilities have agreed to combine in a predominantly all-share transactio
Emera (TSE: EMA) and Canadian Utilities have agreed to combine in a predominantly all-share transact
HALIFAX, Nova Scotia & CALGARY, Alberta--(BUSINESS WIRE)--Emera, ATCO and Canadian Utilities today a
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (TSX/NYSE: EMA) today announces that its Board of
Shares of Emera Incorporated (TSE: EMA - Get Free Report) have earned an average rating of "Moderate
Arcturus Therapeutics Holdings Inc. (the âCompanyâ, âArcturusâ, Nasdaq: ARCT), a messenger R
Engineers Gate Manager LP lifted its position in shares of eMagin Corporation (NYSE: EMA) by 182.6%
[url="]Extreme Networks[/url], Inc. (NASDAQ: EXTR) today announced the general availability of [url=
Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Austra
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the
BATON ROUGE, La., Aug. 12, 2026 /PRNewswire/ -- Bernhard Capital Partners ("Bernhard"), an infrastru
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (TSX/NYSE: EMA) today announced the transaction to
Barclays analyst Michael Lonegan maintains Emera (NYSE:EMA) with a Equal-Weight and lowers the pr
Emera TSE: EMA reported second-quarter adjusted earnings of C$212 million, or C$0.69 per share, as t
Emera (NYSE:EMA) reported quarterly earnings of $0.50 per share which missed the analyst consensus e
Emera (NYSE:EMA) reported quarterly earnings of $0.50 per share which missed the analyst consensus e
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (“Emera”) (TSX/NYSE: EMA) reported 2026 second qua
[url="]PepGen Inc.[/url] (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next g
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of
Wall Street analysts changed outlook on top names. Check analyst ratings page for full view. See wha
Top Wall Street analysts changed outlooks on top stocks. Check out our analyst ratings page for upgr
